Scientific Opinion on the substantiation of health claims related to a combination of <em>Lactobacillus acidophilus</em> BCCM/LMG P-18806, <em>Lactobacillus delbrueckii</em> BCCM/LMG P-18805 and <em>Streptococcus thermophilus</em> BCCM/LMG P-18807 and reduction of gastro-intestinal discomfort (ID 2946, 2951, 2974), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 2946, 2951, 2974), improved lactose digestion (ID 2946, 2951, 2974), and reduction in numbers of circulating CD34+ cells (ID 2947, 2952, 2975) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

<p>Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a scientific opinion on health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 in the framework of further assessment related to a combi...

Full description

Bibliographic Details

Main Author:	EFSA Panel on Dietetic Products, Nutrition and Allergies
Format:	Article
Language:	English
Published:	Wiley 2012-08-01
Series:	EFSA Journal
Subjects:	Lactobacillus acidophilus P-18806 Lactobacillus delbrueckii P-18805 Streptococcus thermophilus P-18807 gastro-intestinal discomfort pathogens lactose digestion CD34+ cells health claims
Online Access:	http://www.efsa.europa.eu/en/efsajournal/doc/2855.pdf